PolyNovo Limited Stock
Stocks
PNV
AU000000PNV0
Medical Equipment, Supplies & Distribution
OTC Markets Traded|
Market Closed -
Australian S.E.
01:10:10 2026-10-19 EDT
|
5-day change | 1st Jan Change | ||
| 0.9200 AUD | -0.54% |
|
-1.60% | -25.20% |
| 09-16 | PolyNovo Limited Announces Board Changes, Effective September 18, 2026 | CI |
| 08-27 | Bell Potter Upgrades PolyNovo to Buy from Hold; Price Target is AU$1.22 | MT |
| Market Cap | 636M 444M 396M 366M 333M 625M 42.08B 4.4B 1.73B 21.99B 1.67B 1.63B 70.31B | P/E 2027 * |
65.3x | P/E 2028 * | 34.4x |
|---|---|---|---|---|---|
| Enterprise Value | 596M 416M 371M 343M 312M 586M 39.43B 4.12B 1.62B 20.61B 1.56B 1.53B 65.88B | EV / Sales 2027 * |
3.68x | EV / Sales 2028 * | 3.12x |
| Free-Float |
90.03% | Yield 2027 * |
-
| Yield 2028 * | - |
| Markets | Quality | ||
|---|---|---|---|
Australian S.E.
| PNV | Delayed | |
OTC Markets
| CALZF | Delayed | |
|
Tradegate
| MFJ | Real-time | |
|
Deutsche Boerse AG
| MFJ | Delayed | |
|
Börse Stuttgart
| MFJ | Delayed | |
|
Boerse Muenchen
| MFJ | Real-time | |
|
Berne S.E.
| MFJ | End-of-day quote |
Last Transcript: PolyNovo Limited
| 25-08-25 | Morgans rates PNV as Speculative Buy | AQ |
| 24-11-25 | Morgans rates PNV as Add | AQ |
| 23-12-07 | Ord Minnett rates PNV as Lighten | AQ |
| 22-04-22 | PolyNovo : Notification regarding unquoted securities - PNV | PU |
| 22-01-23 | PolyNovo : Application for quotation of securities - PNV | PU |
| 1 day | -0.54% | ||
| 1 week | -1.60% | ||
| Current month | -0.54% | ||
| 1 month | -3.16% | ||
| 3 months | -6.12% | ||
| 6 months | -8.91% | ||
| Current year | -25.20% |
| 1 week | 0.88 |  | 0.96 |
| 1 month | 0.88 | | 1 |
| Current year | 0.81 | | 1.3 |
| 1 year | 0.81 | | 1.42 |
| 3 years | 0.81 | | 2.78 |
| 5 years | 0.81 | | 2.78 |
| 10 years | 0.17 | | 4.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bruce Peatey
CEO | Chief Executive Officer | - | 2025-11-30 |
| Director of Finance/CFO | - | 2018-12-11 | |
Marthe D’Ombrain
CTO | Chief Tech/Sci/R&D Officer | - | 2026-05-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Leon Hoare
CHM | Chairman | - | 2025-10-26 |
Robyn Elliott
BRD | Director/Board Member | 65 | 2019-10-27 |
| Director/Board Member | - | 2020-05-12 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 3/16/26 | Buy | Director | 151,000 | 0.0219% | ||
| 2/27/26 | Buy | Director | 100,000 | 0.0145% | ||
| 2/27/26 | Buy | Chairman | 30,000 | 0.0043% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.54% | -1.60% | -27.27% | -23.65% | 445M | |
| -0.79% | +2.09% | -19.73% | +8.92% | 181B | |
| -1.96% | +0.88% | -3.32% | +28.18% | 116B | |
| +1.46% | +5.64% | -21.69% | +11.22% | 113B | |
| -1.52% | +3.61% | -51.56% | -6.22% | 79.83B | |
| -0.08% | +4.59% | +3.84% | +79.04% | 65.06B | |
| -0.27% | +2.10% | +15.54% | +66.81% | 54.35B | |
| -0.35% | +1.15% | +0.04% | -25.79% | 52.23B | |
| -0.70% | +6.37% | -13.38% | +30.92% | 44.15B | |
| +0.01% | +0.01% | +25.57% | -0.13% | 32.47B | |
| Average | -0.49% | +4.55% | -9.20% | +16.93% | 73.9B | |
| Weighted average by Cap. | -0.55% | +5.50% | -12.46% | +19.53% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 162M 113M 101M 93.29M 84.82M 159M 10.71B 1.12B 440M 5.6B 424M 415M 17.9B | 186M 130M 116M 107M 97.36M 183M 12.29B 1.28B 505M 6.43B 487M 476M 20.54B |
| Net income | 9.77M 6.82M 6.08M 5.64M 5.12M 9.61M 647M 67.59M 26.58M 338M 25.61M 25.07M 1.08B | 18.5M 12.92M 11.51M 10.67M 9.7M 18.2M 1.22B 128M 50.31M 640M 48.46M 47.45M 2.05B |
| Net Debt | -40.06M -27.97M -24.93M -23.1M -21M -39.41M -2.65B -277M -109M -1.39B -105M -103M -4.43B | -55.32M -38.63M -34.44M -31.9M -29.01M -54.43M -3.66B -383M -150M -1.91B -145M -142M -6.12B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-19 | A$0.9200 | -0.54% | 395,765 |
| 26-10-16 | A$0.9250 | +3.35% | 587,054 |
| 26-10-15 | A$0.8950 | -2.19% | 683,803 |
| 26-10-14 | A$0.9150 | +1.10% | 625,925 |
| 26-10-13 | A$0.9050 | -4.74% | 2,146,550 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PNV Stock
Select your edition
All financial news and data tailored to specific country editions
